Ionis Pharmaceuticals, Inc. (IONS)
74.23
-1.45
(-1.92%)
USD |
NASDAQ |
May 15, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Ionis Pharmaceuticals Shareholders Equity (Quarterly) : 491.41M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Mirum Pharmaceuticals, Inc. | 242.49M |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.450B |
| Total Liabilities (Quarterly) | 2.959B |
| Debt to Equity Ratio | 5.310 |
| Current Ratio | 4.098 |
| Net Debt Paydown Yield | -1.04% |